MedPath

Moxifloxacin vs. Polytrim for Conjunctivitis

Phase 4
Completed
Conditions
Conjunctivitis
Interventions
Registration Number
NCT00581542
Lead Sponsor
University of Rochester
Brief Summary

The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
124
Inclusion Criteria
  • 1 - 18 years of age with presumed bacterial conjunctivitis.
Exclusion Criteria
  • Previous antibiotics or to receive systemic antibiotic.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Moxifloxacin Opthalmic solutionpolytrim-
Polymyxin B-trimethoprim opthalmic solutionmoxifloxacin-
Primary Outcome Measures
NameTimeMethod
Number of Participants With Normal Physical Examination of the Eye10 days
Secondary Outcome Measures
NameTimeMethod
Number of Participants With a Negative Bacterial Culture10 days

Conjunctival swab specimens were inoculated onto tryptic soy agar with 5% sheep blood and GC II agar supplemented with hemoglobin and isovialex with incubation at 35 degrees C in ambient air supplemented with 5% carbon dioxide for 48 hours. S pneumoniae, H influenzai and M Catarrhalis were identified.

Trial Locations

Locations (1)

University of Rochester

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath